Skip to main content

Analysis of the Potential for Pancreatic Cancer Metastasis In Vitro and In Vivo

  • Protocol
  • First Online:
Pancreatic Cancer

Part of the book series: Methods in Molecular Biology ((MIMB,volume 980))

Abstract

Pancreatic cancer remains a challenging disease, with an overall 5-year survival rate below 5%, the main reason being that it has an extremely high potential for invasion and metastasis. This potential may contribute to the fact that in more than three fourths of patients diagnosed with pancreatic cancer, it has already spread locally and to distant organs, precluding curative resection. Therefore, improved understanding of the mechanisms underlying pancreatic cancer metastasis is urgently needed. In this chapter, we describe our approaches to determining the metastatic potential of pancreatic cancer cells. Specifically, we report the details of these approaches, including in vitro assays of migration, invasion, adhesion, and angiogenesis and in vivo models of liver and lung metastasis and angiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pliarchopoulou K, Pectasides D (2009) Pancreatic cancer: current and future treatment strategies. Cancer Treat Rev 35:431–436

    Article  PubMed  CAS  Google Scholar 

  2. Nieto J, Grossbard ML, Kozuch P (2008) Metastatic pancreatic cancer 2008: is the glass less empty. Oncologist 13:562–576

    Article  PubMed  CAS  Google Scholar 

  3. Seo Y, Baba H, Fukuda T et al (2000) High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 88:2239–2245

    Article  PubMed  CAS  Google Scholar 

  4. Bloomstom M, Zeros EE, Rosemurgy AS II (2002) Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol 9:668–674

    Article  Google Scholar 

  5. Keleg S, Buchler P, Ludwig R et al (2003) Invasion and metastasis in pancreatic cancer. Mol Cancer 2:14

    Article  PubMed  Google Scholar 

  6. Wang B, Wei D, Crum VE et al (2003) A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis. Oncogene 22:1771–1782

    Article  PubMed  CAS  Google Scholar 

  7. Li Q, Wei D, Wang L et al (2010) Modeling liver metastasis using a tumor cell line derived from an enhanced green fluorescent protein transgenic mouse. Clin Exp Metastasis 27:11–18

    Article  PubMed  CAS  Google Scholar 

  8. Wei D, Wang L, He Y et al (2004) Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res 64:2030–2038

    Article  PubMed  CAS  Google Scholar 

  9. Storgard C, Mikolon D, Stupack DG (2005) Angiogenesis assays in the chick CAM. Methods Mol Biol 294:123–136

    PubMed  Google Scholar 

  10. Qiu ZJ, Huang C, Sun J et al (2007) RNAi-mediated STAT3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci 98:1099–1106

    Article  PubMed  CAS  Google Scholar 

  11. Huang C, Jiang T, Zhu L et al (2011) STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo. Int J Oncol 38:1637–1644

    PubMed  CAS  Google Scholar 

  12. Huang C, Cao J, Huang KJ et al (2006) Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cell in vitro. Cancer Sci 97:1417–1423

    Article  PubMed  CAS  Google Scholar 

  13. Marvin MR, Southall JC, Trokhan S et al (1998) Liver metastases are enhanced in homozygous deletionally mutant ICAM-1 or LFA-1 mice. J Surg Res 80:143–148

    Article  PubMed  CAS  Google Scholar 

  14. Huang S, Jean D, Luca M et al (1998) Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 17:4358–4369

    Article  PubMed  CAS  Google Scholar 

  15. Ribatti D, Vacca A, Roncali L et al (2000) The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol 1:73–82

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Don Norwood for editorial comments. This work is ­supported in part by grants R01-CA129956, R01-CA148954, and R01CA152309 (to K. Xie) from the National Cancer Institute, National Institutes of Health, and grant 81101844 (to C. Huang) from the National Natural Science Foundation of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keping Xie .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Huang, C., Xie, K. (2013). Analysis of the Potential for Pancreatic Cancer Metastasis In Vitro and In Vivo. In: Su, G. (eds) Pancreatic Cancer. Methods in Molecular Biology, vol 980. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-287-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-287-2_17

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-286-5

  • Online ISBN: 978-1-62703-287-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics